Form D · Pharmaceuticals
FEMALE HEALTH CO
Chicago, IL · CIK 0000863894
Offering snapshot reported Nov 9, 2016 · SEC filing
- Reported sold
- $22.7M Offering amount: $22.7M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2016 | Initial | $22,676,728 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $974K
- Form D file number
- 021-274155
Based on closing market price of Issuer's common stock on 10/31/16.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Financial West Group | 16668 | · CRD 16668 |
Source: Form D, filed Nov 9, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David R. Bethune | Director |
| Mario Eisenberger | Director |
| Harry Fisch | Director |
| Mary Margaret Frank | Director |
| Daniel Haines | Executive |
| Lucy Lu | Director |
| Georges Makhoul | Director |
| O.B. Parrish | Director |
| Elgar Peerschke | Director |
| Mitchell S. Steiner | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
150 North Michigan Avenue Ste 1580
Chicago, IL, 60601
Chicago, IL, 60601